---
title: "Tuoxin Pharmaceutical: Wholly-owned subsidiary obtains CNAS laboratory accreditation certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257342072.md"
description: "Tuoxin Pharmaceutical announced that its wholly-owned subsidiary, Henan Nucleoside Drug Research Institute Co., Ltd., recently received a laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment. The name of the accredited organization is Henan Nucleoside Drug Research Institute Co., Ltd., and the registration number of the testing and inspection center is CNAS L23965, with an effective date of September 1, 2025, and an expiration date of August 31, 2031"
datetime: "2025-09-15T10:27:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257342072.md)
  - [en](https://longbridge.com/en/news/257342072.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257342072.md)
generator: "portal-rs"
---

# Tuoxin Pharmaceutical: Wholly-owned subsidiary obtains CNAS laboratory accreditation certificate

Tuoxin Pharmaceutical announced that its wholly-owned subsidiary, Henan Nucleoside Drug Research Institute Co., Ltd., recently received a laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment. The name of the accredited organization is Henan Nucleoside Drug Research Institute Co., Ltd., and the registration number of the testing and inspection center is CNAS L23965, with an effective date of September 1, 2025, and an expiration date of August 31, 2031

### Related Stocks

- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)

## Related News & Research

- [Top Economist Takes Aim at Kevin Warsh’s Fed: Is Trump’s New Chair an Independent ‘Hawky Hawk’ or a ‘MAGA Sock Puppet’?](https://longbridge.com/en/news/297519761.md)
- [Security Risk Advisors Launches SCALR AI as a Free SOC AI Platform for Security Teams](https://longbridge.com/en/news/297523531.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Trump announces Medicaid drug pricing deals with 9 firms](https://longbridge.com/en/news/297557074.md)
- [The biggest "lobster" has been released: OpenClaw 2.0 aims to solve three major problems for agents.](https://longbridge.com/en/news/297578236.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**